AgeneBio gets grants to advance therapeutics to slow Alzheimer's disease

The NIH grants for an expected $16 million will help the company with Phase 3 trials.

Related Keywords

Washington ,United States ,Melvinr Goodes ,Michela Gallagher ,Sharon Rosenzweig Lipson ,Johns Hopkins University ,Johns Hopkins Center ,National Institutes Of Health ,Alzheimer Drug Discovery Foundation ,Alzheimer Association ,Behavior Center ,National Institute Of Neurological Disorders ,Baltimore Based Agenebio ,National Institutes ,National Institute ,Neurological Disorders ,Mild Cognitive Impairment ,Cerveau Technologies ,Imaging Science ,Vice President ,Drug Discovery ,Drug Discovery Foundation ,